KRAS and lung carcinoma: It is interesting to note that the links between peroxisomal-based processes, the TCA cycle, and metabolic rewiring were first described for KRAS-mutated lung cancer [85], and additional links between this oncogenic driver mutation and the key regulators of metabolic processes have now been described [79].